Roselabs Finance Ltd. (ROSELABS) — Tipsheet https://tipsheet.markets/company/roselabs/ Every Tipsheet Editorial note covering Roselabs Finance Ltd. (ROSELABS), newest first. Grounded in BSE/NSE primary-source filings. en-in Tue, 28 Jul 2026 14:38:35 GMT Roselabs files merger with Lodha Developers at NCLT, net loss widens to ₹5.47 lakh https://tipsheet.markets/roselabs-roselabs-files-merger-with-lodha-developers-at-nclt-net-loss-widens-to-5-47-lakh-123559/ https://tipsheet.markets/roselabs-roselabs-files-merger-with-lodha-developers-at-nclt-net-loss-widens-to-5-47-lakh-123559/ Fri, 17 Jul 2026 16:35:53 GMT Quarterly loss crept higher to ₹5.47 lakh with no operating revenue. The bigger story: the merger with Lodha Developers is now before the NCLT for approval. Quarterly loss crept higher to ₹5.47 lakh with no operating revenue. The bigger story: the merger with Lodha Developers is now before the NCLT for approval.

What’s new

  • Net loss for Q1 FY27 stood at ₹5.47 lakh, up from ₹4.68 lakh a year ago.
  • The merger with Lodha Developers Ltd has been filed with the NCLT Mumbai for approval.
  • No revenue from operations reported; company remains in financial stress.

Why it matters

A merger with Lodha Developers could give Roselabs a new lease of life. But with no operating revenue and a widening loss, the company's future hinges entirely on regulatory clearance. For a ₹21-cr market cap entity, this is a binary event.

What we’re watching

  • NCLT approval timeline, critical for the merger's consummation.
  • Any improvements in operating performance before the merger closes.
  • Disclosure of the merger scheme's valuation and share swap ratio.

The full read

Routine quarter. Net loss came in at ₹5.47 lakh, up from ₹4.68 lakh a year ago, and the company booked no operating revenue. The more consequential news: its merger with Lodha Developers Ltd has been filed with the NCLT in Mumbai and is awaiting approval, a binary catalyst for a ₹21-crore nano-cap with no revenue and a widening loss. This is a procedural update. The next test is regulatory approval.

Primary source: BSE · NSE

]]> Earnings Tipsheet Editorial